Squarepoint’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2K | Buy |
+58,307
| New | +$24.2K | ﹤0.01% | 2660 |
|
|
2024
Q4 | – | Sell |
-137,983
| Closed | -$251K | – | 2750 |
|
|
2024
Q3 | $251K | Buy |
+137,983
| New | +$251K | ﹤0.01% | 2083 |
|
|
2024
Q2 | – | Sell |
-106,356
| Closed | -$1.19M | – | 2459 |
|
|
2024
Q1 | $1.19M | Buy |
+106,356
| New | +$1.19M | ﹤0.01% | 1277 |
|
|
2023
Q2 | – | Sell |
-63,231
| Closed | -$286K | – | 2370 |
|
|
2023
Q1 | $286K | Buy |
+63,231
| New | +$286K | ﹤0.01% | 1703 |
|
|
2022
Q4 | – | Sell |
-13,615
| Closed | -$130K | – | 2231 |
|
|
2022
Q3 | $130K | Buy |
+13,615
| New | +$130K | ﹤0.01% | 1859 |
|
|
2022
Q2 | – | Sell |
-13,189
| Closed | -$223K | – | 2096 |
|
|
2022
Q1 | $223K | Sell |
13,189
-34,016
| -72% | -$575K | ﹤0.01% | 1864 |
|
|
2021
Q4 | $1.01M | Buy |
+47,205
| New | +$1.01M | ﹤0.01% | 1208 |
|